Phase 2 study for people with Lung Cancer

Recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 2
Sponsor BlossomHill Therapeutics
Registry number NCT06706076
Started 9 January 2025 Today 16 October 2026 Estimated completion 31 January 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Austin Health Heidelberg VIC Recruiting
Peter MacCallum Cancer Centre Melbourne VIC Recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 675

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* ≥ 18 years or legal adult.

* Pathologically confirmed diagnosis of locally advanced or metastatic NSCLC with EGFR or HER2 mutations in the kinase domain of exons 18, 19, 20, or 21.

* Has at least 1 measurable target extracranial lesion according to RECIST v1.1.

* Eastern Cooperative Oncology Group Performance Status ≤ 1.

* Has a life expectancy of ≥ 3 months.

* Has adequate hematologic, hepatic, and renal function.

* The above are a summary; other Inclusion Criteria details may apply.

Exclusion Criteria:

* History of any concurrent malignancy within the previous 2 years.

* Known other oncogenic driver alterations (eg, moderate or high MET amplification) or histological transformation (eg, to small cell carcinoma, etc.).

* Unresolved toxicities from prior therapies.

* Any significant and uncontrolled medical condition, such as infection.

* Active or history of interstitial lung disease from any cause

* Clinically significant cardiovascular event within 6 months or significant history of major organ.

* The above are a summary; other Exclusion Criteria details may apply.

Dates on the record

Started 9 January 2025
Estimated completion 31 January 2029
Registry last updated 5 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 5 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.